<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Achieved record revenue of NIS 45 million (over CAD$17 million), an increase of 400% year-over-year and over 35% quarter-over-quarter Achieved quarterly run-rate Q2 Pro Forma[1] revenues of NIS 55 million (over CAD$21.4 million) Recorded continued increase in operating profit, EBITDA[2] and net profit Achieved Q2 EBITDA margin of 26% and positive operational cash flow Revenue growth expected to continue in the third quarter and for the remainder of 2021 Completed all SEC filings for listing of shares on the NASDAQ TORONTO and HERZLIYA, Israel, Aug. 16, 2021 /PRNewswire/ — InterCure Ltd. (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (the “Company”) is pleased to announce its financial results for the second quarter of 2021 and provide a business update.
...read full article on PRNewsWire
